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Background
Many recent studies have shown the superior diagnostic
accuracy of specific IgE (sIgE) to Ara h 2 compared to
sIgE to peanut extract in diagnosing peanut allergy. The
aim of this study was to analyze the association between
severity and sensitization levels (by SPT, sIgE to peanut
extract and peanut components Ara h 1, 2, 3 and 8).
Methods
Peanut allergic adults (n=94) and children (n=100) with
a suspected peanut allergy were included. sIgE levels
were measured by ImmunoCAP (Uppsala, Sweden). In
all subjects the adapted Mueller score was used with
one additional category for no symptoms (0-5): 0; no
symptoms/peanut tolerant, 1; oral allergy symptoms, 2;
cutaneous/mucosal symptoms, 3; gastrointestinal symp-
toms, 4; respiratory symptoms, 5; cardiovascular symp-
toms. A severe reaction was defined as a Mueller score
of 4 or 5. Univariate and multivariate logistic regression
analysis was used to calculate odds ratio’s.
Results
Children had significantly higher Mueller scores than
adults (P=0.003) and were therefore analyzed separately.
In children 12 patients had a severe allergy, in adults 15
patients. In the pediatric population, none of the predic-
tors was significantly associated with a severe peanut
allergy, since the 95% CI of the OR of all predictors
included the value 1. In the adult population, sIgE to Ara
h 2 (OR 1.03, 95% CI 1.01-1.06) and sIgE to peanut
extract (OR 1.02, 95% CI 1.003-1.05) were significantly
associated with a severe peanut allergy. A multivariable
logistic regression analysis was not possible due to the
low number of severely allergic patients. The AUC values
of sIgE to Ara h 2 and sIgE to peanut extract in the adult
population were 0.81 (95% CI 0.69-0.93) and 0.70 (95%
CI 0.54-0.86), respectively (compared to 0.77 (0.64-0.89)
and 0.69 (0.53-0.85) in the pediatric population).
Conclusion
In children no predictor was significantly associated with
severity of peanut allergy. In adults, specific IgE to Ara h 2
was a better predictor for severe peanut allergy than sIgE
to peanut extract, but was still suboptimal for this purpose.
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